Blurbs

Nutrien (NTR) Gets a Buy Rating from UBS

UBS analyst Andrew Stott maintained a Buy rating on Nutrien (NTRResearch Report) yesterday and set a price target of $94.00. The company’s shares closed last Monday at $83.83.

According to TipRanks.com, Stott is a 4-star analyst with an average return of 10.3% and a 61.6% success rate. Stott covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, Clariant AG, and LANXESS.

Nutrien has an analyst consensus of Moderate Buy, with a price target consensus of $85.07, representing a 4.4% upside. In a report issued on February 18, Barclays also maintained a Buy rating on the stock with a $92.00 price target.

See today’s best-performing stocks on TipRanks >>

Nutrien’s market cap is currently $46.08B and has a P/E ratio of 14.67.

Based on the recent corporate insider activity of 23 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of NTR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Canada-based Nutrien Ltd. is a crop nutrient company, which produces and distributes potash, nitrogen and phosphate products for agricultural, industrial and feed manufacturers.

Read More on NTR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos